Author Archives: admin


Stem Cell Clinic > Articles by: admin

Early stem cell transplant may cure "bubble boy" disease

By Stem Cell Treatment

"Bubble boy" David Vetter lived in a protective environment designed by NASA engineers. He died of complications after receiving a bone marrow transplant in 1984, at the age of 12. Baylor College of Medicine Photo Archives

Babies born with so-called "bubble boy" disease can often be cured with a stem cell transplant, regardless of the donor -- but early treatment is critical, a new study finds.

Severe combined immunodeficiency (SCID), as the condition is medically known, actually refers to a group of rare genetic disorders that all but eliminate the immune system. That leaves children at high risk of severe infections.

The term "bubble boy" became popular after a Texas boy with SCID lived in a plastic bubble to ward off infections. The boy, David Vetter, died in 1984 at the age of 12, after an unsuccessful bone marrow transplant -- an attempt to give him a functioning immune system.

15 Photos

Immune disorder forced David Vetter to live in bubble - but breakthroughs from his story now enable similar kids to live free

In the best-case scenario, a child would get stem cells -- the blood-forming cells within bone marrow -- from a sibling who is a perfect match for certain immune-system genes.

But that's not always an option, partly because kids with SCID are often their parents' first child, said Dr. John Cunningham, director of hematopoietic stem cell transplantation at the University of Chicago Comer Children's Hospital. He was not involved in the study.

In those cases, doctors typically turn to a parent -- who is usually a "half" match, but whose stem cells can be purified to improve the odds of success. Sometimes, stem cells from an unrelated, genetically matched donor can be used.

The good news: Regardless of the donor, children with SCID can frequently be cured, according to the new findings. But early detection and treatment is vital.

Read the original:
Early stem cell transplant may cure "bubble boy" disease

Extracted fat put forward as cure for wobbly knees

By Stem Cell Doctors

Mary Ann Benitez

Thursday, July 31, 2014

Health Innovative Technology chief executive Matthew Fan Chun-yin said his company is banking on the fat graft's potential as a drug in future and acquired ProStemCell last year to expand its bio- bank storage and research capabilities.

The government plans to issue new rules and regulations governing stem cell laboratories, he said.

During a tour of the laboratories of HIT ProStemCell in Kowloon Bay, Fan said scientists discovered stem cells from the extracted fat stimulate the repair of the knee cartilage and relieves pain for osteoarthritic patients.

He said it was unfortunate that liposuction has been tarnished by the death of a dance teacher and studio owner Josephine Lee Ka-ying, 32, who fell comatose and died after a four-hour liposuction treatment at the Regrowth Hair Transplant Centre in Tsim Sha Tsui on June 27 this year.

"You should not do any liposuction in a non-qualified day surgery center," said Fan, a former dietician.

He said ProStemCell, which HIT acquired last year, built a "clean-room" laboratory four years ago which meets the US Food and Drug Administration's standards.

The classification is the same required of companies for drug manufacturing and for hospital operating theaters which do open-heart surgery.

ProStemCell built the laboratory because the administration put out guidelines in 2009 requiring such stringent laboratory guidelines.

Read more:
Extracted fat put forward as cure for wobbly knees

Regenerative Medicine Solutions – Home – Stem Cell …

By Stem Cell Medicine

Regenerative Medicine Solutions (RMS) is a leading global provider of Stem Cell Treatments, Platelet-Rich Plasma (PRP), Natural Growth Factors and other innovative regenerative medical technologies,for the treatment of an array of debilitating medical conditions. Through our individualized, patient-centric approach, we are providing the highest quality of care and consistent positive outcomes. By applying todays best practices to the growing field of regenerative medicine RMS is changing lives.

RMS is results-driven, having positively improved the quality of life for hundreds of patients. At RMS, the safety of every patient is our top priority. All of the procedures performed at RMSs state-of-the-art clinics are in compliance with the highest standards of safety. The quality of care provided by our team of medical experts is unsurpassed in the industry.

RMS is sensitive to the distressing nature of our patients conditions, therefore our focus is to provide them with a superior level of personalized care and to make them comfortable throughout the entire treatment process. Supported by ground breaking developments in clinical science and stem cell therapy, RMS is welcoming the future of medicine through the application of our innovative regenerative technologies.

100%

of procedures are outpatient

100%

of procedures are minimally invasive

100+

years of combined physician experience

500+

Originally posted here:
Regenerative Medicine Solutions - Home - Stem Cell ...

Stem Cells to Renew the Health and Lives of People – Aishwarya Rai Bachchan in Chennai – Video

By Uncategorized


Stem Cells to Renew the Health and Lives of People - Aishwarya Rai Bachchan in Chennai
Stem Cells to Renew the Health and Lives of People - Aishwarya Rai Bachchan in Chennai - RedPix 24x7 #AishwaryaRai #AishwaryaRaiBachchan #StemCells #LifeCell LifeCell is India #39;s first and...

By: Red Pix 24x7

See original here:
Stem Cells to Renew the Health and Lives of People - Aishwarya Rai Bachchan in Chennai - Video

Chris Johnson Opens Up About Stem Cell Treatment with the MMQB

By Stem Cell Treatment

Chris Johnson was once the most dynamic running back in the NFL. Now, following his move from the Tennessee Titans to the New York Jets, he's hoping cutting-edge medical treatment can help him return to those previous levels of production and extend his career.

Jenny Vrentas of The MMQB reports Johnson underwent stem-cell treatment as part of his recovery from an injury to his left knee. Dr. James Andrews, who's well known for his work with athletes across the sports spectrum, handled the procedure.

The three-time Pro Bowl ball-carrier explained he suffered meniscus damage in Week 3 last season, but he decided to fight through the injury. While he ended up playing in all 16 games, he certainly didn't look like the player Titans fans once knew.

At 28, he's entering a period when most running backs begin to fade due to the cumulative damage after years of absorbing hits and general fatigue. Johnson hopes the treatment can help him avoid that drop-off.

"When I tore my meniscus and played the season out, through the wear and tear, I lost a lot of cartilage," he told Vrentas. "When you put the stem cells in, it might be able to help rebuild that cartilage in your knee. Hopefully, it makes your knee better for even more years."

Vrentas also spoke with Andrews, who states there are still question marks surrounding the benefits of the treatments. Still, he's trying to help the research pick up steam stateside so players won't have to keep going to Europe or elsewhere, making it unclear exactly what they're being provided with.

Ultimately, his hope is combining the stem-cell treatments with normal recovery methods like surgery can further accelerate how quickly athletes get back in the game.

"Instead of taking a year, a year and a half in order to get well, maybe we can cut that down in half," he said. "We have an old saying: 'You can't bargain with Mother Nature.' The biologics, the stem-cell therapy, is the revelation that may change that."

If Johnson can showcase the form that allowed him to rush for more than 2,000 yards en route to being named the AP Offensive Player of the Year in 2009, perhaps Andrews' wish will begin to take shape.

The returns are promising so far. Manish Mehta of the New York Daily News pegged Johnson as one of the standout players early in Jets training camp:

Read this article:
Chris Johnson Opens Up About Stem Cell Treatment with the MMQB

Lung Institutes Medical Director Celebrates 55th Anniversary in Medical Practice

By Stem Cell Medicine

Tampa, FL (PRWEB) July 29, 2014

This month marks a milestone for the Lung Institutes Medical Director, Dr. Burton Feinerman, as he celebrates his 55th anniversary in the medical field. Practicing medicine for over half a century, Dr. Feinerman has distinguished himself as a world-renowned physician in the field of regenerative medicine with the development of innovative stem cell treatments for lung diseases like chronic obstructive pulmonary disease (COPD).

Dr. Feinermans medical career has been punctuated by many firsts. In the 1950s and 1960s, Dr. Feinerman was the owner of Opa-Locka General Hospital, the only private hospital accepting African Americans in Miami, Florida. He also set up the first Pediatric Emergency Rooms in South Florida at Parkway Hospital and Miami General Hospital.

The Lung Institutes medical director was also involved with the first successful allogeneic (genetically dissimilar) bone marrow transplant performed on a 10-month-old child with severe combined/immunodeficiency, known as bubble baby. This patient, who was given a very poor prognosis of life expectancy, is now 36-years-old and a high school teacher. In 1998, Dr. Feinerman set up the first medical service website site, Webmedicalservices.com, to directly answer patient questions, which later became a public company.

It was during his time in Hawaii as the first physician to offer cosmetic dermatology and anti-aging medicine that Dr. Feinerman initially became interested in stem cells. Over subsequent years, he developed stem cell patents for a variety of disorders including Amyotrophic Lateral Sclerosis (ALS), Parkinsons, Alzheimers, multiple sclerosis, autism, cerebral palsy, COPD, pulmonary fibrosis, diabetes types 1 and 2, end-stage kidney disease and brain damage in children and adults. He also developed patents for gene therapies to treat such conditions as Tay-Sachs, Sandhoff disease, Huntingtons disease and metachromatic leukodystrophy.

Dr. Feinermans stem cell quest continues at Regenerative Medicine Solutions and Lung Institute, with his current research aimed at conquering neurological and chronic lung diseases as well as diseases causing blindness such as age-related macular degeneration, retinitis pigmentosa, and stargardts disease.

I am humbled at the acknowledgement of my role as a catalyst for change in medicine, confessed Dr. Feinerman who was honored last year as Lifetime Achievement Award finalist for the Tampa Bay Business Journals Healthcare Heroes. When I reflect back on my medical career, I only see my patients.

About the Lung Institute At the Lung Institute, we are changing the lives of hundreds of people across the nation through the innovative technology of regenerative medicine. We are committed to providing patients a more effective way to address pulmonary conditions and improve quality of life. Our physicians, through their designated practices, have gained worldwide recognition for the successful application of revolutionary minimally invasive stem cell therapies. With over a century of combined medical experience, our doctors have established a patient experience designed with the highest concern for patient safety and quality of care. For more information, visit our website at LungInstitute.com, like us on Facebook, follow us on Twitter or call us today at (855) 469-5864.

See the rest here:
Lung Institutes Medical Director Celebrates 55th Anniversary in Medical Practice

Beware of claims about cosmetic stem cells procedures, says review in Plastic and Reconstructive Surgery

By Stem Cell Medical Center

PUBLIC RELEASE DATE:

29-Jul-2014

Contact: Connie Hughes Connie.Hughes@wolterskluwer.com 646-674-6348 Wolters Kluwer Health

July 29, 2014 Advertising claims for cosmetic procedures using stem cells are running far ahead of the scientific evidence for safety and effectiveness, according to a review in the August issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).

"Stem cells offer tremendous potential, but the marketplace is saturated with unsubstantiated and sometimes fraudulent claims that may place patients at risk," write Dr Michael T. Longaker of Stanford University Medical Center and colleagues.

'Worrying advertisements' for cosmetic stem cell procedures

Dr Longaker and coauthors raise concerns about the unregulated use of stem cells for unproven indicationsincluding cosmetic procedures. While stem cell therapy "remains in its infancy," they write, "there are a growing number of cosmetic practitioners that are advertising minimally invasive, stem cell-based rejuvenation procedures."

The article was prompted by "worrying advertisements" claiming benefits of stem cell procedures for facelifts, breast augmentationeven "stem cell vaginal rejuvenation." These ads claim benefits from procedures that have not undergone rigorous scientific evaluationincluding potential risks related to stem cell and tissue processing and the effects of aging on stem cells.

To gain insight into these claims, Dr Longaker and coauthors performed a Google search for cosmetic stem cell treatments, the most common of which was "stem cell facelifts." Most procedures used "stem cells" isolated from fat. However, the websites provided little information on the quality of the stem cells used.

Without advanced cell-sorting procedures, these products used in these procedures likely contain many other types of cells besides fat-derived stem cells. Many clinics also offered plasma-rich platelet protein treatments, which they inaccurately marketed as stem cell therapy.

Read more from the original source:
Beware of claims about cosmetic stem cells procedures, says review in Plastic and Reconstructive Surgery

Stem Cell Therapy, Stem Cell Research, Stem Cell Treatments

By Stem Cell Clinic

Welcome to the Silicon Valley Stem Cell Treatment Center, and affiliate of the California Stem Cell Treatment Center. At our state of the art clinic we are using cutting edge advanced techniques and the latest innovative technology to improve the health and well being of our patients. At Silicon Valley Stem Cell Treatment Center, we provide care for people suffering from diseases that may have limited treatment options and may respond to stem cell based regenerative treatment. The Silicon Valley Stem Cell Treatment Center emphasizes quality and our well trained physician is highly committed to clinical research and the advancement of regenerative medicine.

The California Stem Cell Treatment specialists who trained our physician, have been nationally recognized for working with autologous (your own) adipose derived stem cells providing investigational therapy to patients with various inflammatory and/or degenerative conditions. Our Centers utilize a fat transfer technology to isolate and implant the patient's own stem cells from a small quantity of fat harvested by liposuction on the same day. Using technology developed in South Korea, our group has developed an in office procedure to isolate this cellular medium called the Stromal Vascular Fraction or SVF which is very rich in stem cells. Our founders have also worked in conjunction with a number of international organizations and physicians of great expertise to help develop our protocols for procedures. In 2012, the Cell Surgical Network (CSN) was formed, of which we are an affiliate, to provide the same high level quality controlled investigational therapy nationwide and beyond. Under our IRB (Institutional Review Board) approved protocol, we in Silicon Valley are now also able to provide fat derived stem cell procedures on an investigational basis. Modeled after the California Stem Cell Treatment Center, we've formed a multidisciplinary team to evaluate patients with a variety of conditions often responsive to Stem Cell therapy. All affiliate members in the CSN, including our clinic will contribute to the California Centers IRB approved investigation. Patients who seek care at the Silicon Valley Stem Cell Treatment Center will be evaluated by one of our physicians and given our honest opinion as to the potential benefits and risks of stem cell therapy for their presenting condition.

California Stem Cell Treatment Center was founded in 2010 for the investigational use of stem cells procedures for degenerative conditions. California Stem Cell Treatment Center employs a clinical research coordinator to protect our valuable data, as our vision is to perfect our treatments and ultimately teach them to others.

Read the original post:
Stem Cell Therapy, Stem Cell Research, Stem Cell Treatments

→←